- ARTL Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-KT Filing
Artelo Biosciences (ARTL) 10-KT2022 Q1 Annual report (with FYE transition)
Filed: 21 Mar 22, 8:32am
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-3 (File no. 333-235915) and Forms S-8 (File Nos. 333-251387, 333-239434 and 333-235916) of our report dated March 18, 2022 with respect to the audited consolidated financial statements of Artelo Biosciences, Inc. (the “Company”) appearing in this Annual Report on Form 10-KT of the Company for the period ended December 31, 2021.
/s/ MaloneBailey, LLP
www.malonebailey.com
Houston, Texas
March 18, 2022
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.